Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis
Amelie Franken, Pierre Van Mol, Sam Vanmassenhove, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005323-e005323
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 40
Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy
Chuan Liu, Jindong Xie, Bo Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 26
Pulmonary toxicity of immune checkpoint immunotherapy
Mohammad I. Ghanbar, Karthik Suresh
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 23
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
Betul Ibis, Konstantinos Aliazis, Carol Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
Meixi Lin, Dan Zang, Chenguang Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Exploring the anti-inflammatory effects of Radix Curcumae essential oil in pulmonary sarcoidosis via the TLR4/MyD88/NF-κB pathway
Zhiguo Mao, Xia Lin, Yilong Hu, et al.
Phytomedicine (2025) Vol. 139, pp. 156496-156496
Closed Access | Times Cited: 1
Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors
Zi Xin Wan, Jiangyuan Huang, Xiaojie Ou, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 3, pp. 425-432
Open Access | Times Cited: 5
CD4 T cells and toxicity from immune checkpoint blockade
Noah Earland, Wubing Zhang, Abul Usmani, et al.
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 96-109
Closed Access | Times Cited: 10
Immune-checkpoint Inhibitors in Anti-cancer Armamentarium: a Double-edged Sword in Risk of Developing Autoimmunity and Immune-related Adverse Effects

Frontiers research topics (2025)
Closed Access
Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
Lei Sun, Jinhao Zhang, Zhikai Xiahou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy
Tingyue Luo, Wei‐Sheng Chen, Danhui Huang, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152884-152884
Open Access
Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future
Jie Mei, Yinong Chen, Huixiang Tian, et al.
The Innovation Medicine (2025), pp. 100115-100115
Closed Access
Single-cell transcriptome sequencing reveals the immune microenvironment in bronchoalveolar lavage fluid of checkpoint inhibitor-related pneumonitis
Linpeng Zheng, Feng-Lin Lin, Dingqin Cai, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directions
Yan Xu, Ruxuan Chen, Ruili Pan, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2025) Vol. 3, Iss. 1, pp. 29-40
Open Access
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies
H. Jia, Yanjie Bian, Jie Yuan, et al.
Translational Oncology (2025) Vol. 55, pp. 102364-102364
Closed Access
Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib
Menghui Wang, Yueheng Li, Junhui Su, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Single Cell and Spatial Omics and Applications in Toxicology
David A. Gallegos, Dakota R. Robarts, David S. Umbaugh
Elsevier eBooks (2025)
Closed Access
Immune checkpoint inhibitor-associated pneumonitis: focus on diagnosis and underlying mechanisms
Mtanis Khoury, Saadia A. Faiz, Ajay Sheshadri
Current Opinion in Pulmonary Medicine (2025)
Closed Access
Immune-Related Toxicity in NSCLC: Current State-of-the-Art and Emerging Clinical Challenges
Claire E. T. O'Leary, Nicole Pierce, Sandip Pravin Patel, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 3, pp. 395-408
Open Access | Times Cited: 9
Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis
Pengfei Cui, Jinfeng Li, Haitao Tao, et al.
Oncogene (2023) Vol. 42, Iss. 42, pp. 3098-3112
Open Access | Times Cited: 7
Immune Checkpoint Inhibitor Myopathy
Grayson Beecher, Iago Pinal‐Fernandez, Andrew L. Mammen, et al.
Neurology (2024) Vol. 103, Iss. 11
Closed Access | Times Cited: 2
Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review
Lei Pan, Fanqi Meng, Wei Wang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 6
Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis
Pengmei Wang, Zhongwei Zhang, Shan Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8019-8026
Open Access | Times Cited: 6
Rheumatic complications of checkpoint inhibitors: Lessons from autoimmunity
Gary Reynolds
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 51-60
Open Access | Times Cited: 6
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer
Liang Zeng, Yuling Zhou, Qinqin Xu, et al.
Lung Cancer (2023) Vol. 184, pp. 107350-107350
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top